FDA Approved: NITROFURANTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nitrofurantoin submitted by Rising Pharma Holdings, Inc. to modify the labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Nitrofurantoin (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (NITROFURANTOIN)